img

Glucagon Like Peptide-1 (GLP-1) Agonists


Published on: 2024-01-04 | No of Pages : 144 | Industry : Pharma & Healthcare

Publisher : HNY Research | Format : PDF&Excel

Glucagon Like Peptide-1 (GLP-1) Agonists

The global Glucagon Like Peptide-1 (GLP-1) Agonists market was valued at 490.85 Million USD in 2021 and will grow with a CAGR of 13.37% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of Liraglutide diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015. The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28% in 2015. Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

By Market Verdors

Novo Nordisk

AstraZeneca

Eli Lilly

GSK

Sanofi

Bristol-Myers Squibb

Amylin



By Types

Exenatied

Liraglutide

Lixisenatide

Albiglutide

Dulaglutide



By Applications

Hospital

Pharmacy



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue

1.4 Market Analysis by Type

1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Exenatied

1.4.3 Liraglutide

1.4.4 Lixisenatide

1.4.5 Albiglutide

1.4.6 Dulaglutide

1.5 Market by Application

1.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application: 2022-2027

1.5.2 Hospital

1.5.3 Pharmacy

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Glucagon Like Peptide-1 (GLP-1) Agonists Market

1.8.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Region (2016-2021)

3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share by Region (2016-2021)

3.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume

3.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume

3.4.1 East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.4.2 East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.5.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.5.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.6.1 South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.6.2 South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.7.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.7.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.8.1 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.8.2 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.9.1 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.9.2 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.10.1 Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.10.2 Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.11.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.11.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (2016-2021)

3.12.1 Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

3.12.2 Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

4 North America

4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

4.2 United States

4.3 Canada

4.4 Mexico

5 East Asia

5.1 East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

5.2 China

5.3 Japan

5.4 South Korea

6 Europe

6.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

6.2 Germany

6.3 United Kingdom

6.4 France

6.5 Italy

6.6 Russia

6.7 Spain

6.8 Netherlands

6.9 Switzerland

6.10 Poland

7 South Asia

7.1 South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

7.2 India

7.3 Pakistan

7.4 Bangladesh

8 Southeast Asia

8.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

8.2 Indonesia

8.3 Thailand

8.4 Singapore

8.5 Malaysia

8.6 Philippines

8.7 Vietnam

8.8 Myanmar

9 Middle East

9.1 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

9.2 Turkey

9.3 Saudi Arabia

9.4 Iran

9.5 United Arab Emirates

9.6 Israel

9.7 Iraq

9.8 Qatar

9.9 Kuwait

9.10 Oman

10 Africa

10.1 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

10.2 Nigeria

10.3 South Africa

10.4 Egypt

10.5 Algeria

10.6 Morocco

11 Oceania

11.1 Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

11.2 Australia

11.3 New Zealand

12 South America

12.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

12.2 Brazil

12.3 Argentina

12.4 Columbia

12.5 Chile

12.6 Venezuela

12.7 Peru

12.8 Puerto Rico

12.9 Ecuador

13 Rest of the World

13.1 Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries

13.2 Kazakhstan

14 Sales Volume, Sales Revenue, Sales Price Trend by Type

14.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2016-2021)

14.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share by Type (2016-2021)

14.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price by Type (2016-2021)

15 Consumption Analysis by Application

15.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume by Application (2016-2021)

15.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Value by Application (2016-2021)

16 Company Profiles and Key Figures in Glucagon Like Peptide-1 (GLP-1) Agonists Business

16.1 Novo Nordisk

16.1.1 Novo Nordisk Company Profile

16.1.2 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 AstraZeneca

16.2.1 AstraZeneca Company Profile

16.2.2 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 Eli Lilly

16.3.1 Eli Lilly Company Profile

16.3.2 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.3.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 GSK

16.4.1 GSK Company Profile

16.4.2 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 Sanofi

16.5.1 Sanofi Company Profile

16.5.2 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 Bristol-Myers Squibb

16.6.1 Bristol-Myers Squibb Company Profile

16.6.2 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.7 Amylin

16.7.1 Amylin Company Profile

16.7.2 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

16.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Analysis

17.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis

17.1.1 Key Raw Materials

17.2 Proportion of Manufacturing Cost Structure

17.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

17.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis

18 Marketing Channel, Distributors and Customers

18.1 Marketing Channel

18.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List

18.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers

19 Market Dynamics

19.1 Market Trends

19.2 Opportunities and Drivers

19.3 Challenges

19.4 Porter's Five Forces Analysis

20 Production and Supply Forecast

20.1 Global Forecasted Production of Glucagon Like Peptide-1 (GLP-1) Agonists (2022-2027)

20.2 Global Forecasted Revenue of Glucagon Like Peptide-1 (GLP-1) Agonists (2022-2027)

20.3 Global Forecasted Price of Glucagon Like Peptide-1 (GLP-1) Agonists (2016-2027)

20.4 Global Forecasted Production of Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2022-2027)

20.4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.2 East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.4 South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.6 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.7 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.8 Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.9 South America Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.4.10 Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2022-2027)

20.5 Forecast by Type and by Application (2022-2027)

20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

20.5.2 Global Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2022-2027)

21 Consumption and Demand Forecast

21.1 North America Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.2 East Asia Market Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.3 Europe Market Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Countriy

21.4 South Asia Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.5 Southeast Asia Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.6 Middle East Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.7 Africa Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.8 Oceania Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.9 South America Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

21.10 Rest of the world Forecasted Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists by Country

22 Research Findings and Conclusion

23 Methodology and Data Source

23.1 Methodology/Research Approach

23.1.1 Research Programs/Design

23.1.2 Market Size Estimation

23.1.3 Market Breakdown and Data Triangulation

23.2 Data Source

23.2.1 Secondary Sources

23.2.2 Primary Sources

23.3 Disclaimer



List of Figure

Key Players Covered: Ranking by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) 2016-2021

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type (US$ Million): 2022-2027

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application (US$ Million): 2022-2027

Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity by Manufacturers

Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Manufacturers (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Manufacturers (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2016-2021)

Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price of Key Manufacturers (2016-2021)

Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served

Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Region (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Region (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue by Region (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share by Region (2016-2021)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Region (2016-2021)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Type (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue by Type (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Share by Type (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price by Type (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume by Application (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume Market Share by Application (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Value by Application (2016-2021)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Value Market Share by Application (2016-2021)

Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List

Glucagon Like Peptide-1 (GLP-1) Agonists Customers List

Market Key Trends

Key Opportunities and Drivers: Impact Analysis (2022-2027)

Key Challenges

Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Forecast by Region (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Forecast by Type (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share Forecast by Type (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Forecast by Type (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share Forecast by Type (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Forecast by Type (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume Forecast by Application (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Value Forecast by Application (2022-2027)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

South America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Rest of the world Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027 by Country

Research Programs/Design for This Report

Key Data Information from Secondary Sources

Key Data Information from Primary Sources





Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type: 2021 VS 2027

Exenatied Features

Liraglutide Features

Lixisenatide Features

Albiglutide Features

Dulaglutide Features

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application: 2021 VS 2027

Hospital Case Studies

Pharmacy Case Studies

Glucagon Like Peptide-1 (GLP-1) Agonists Report Years Considered

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Status and Outlook (2016-2027)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Value) and Growth Rate (2016-2027)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Growth Rate (2016-2021)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Canada Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Japan Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Region in 2021

Germany Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

United Kingdom Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

France Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Italy Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Russia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Spain Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Netherlands Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Switzerland Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Poland Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

India Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Pakistan Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Bangladesh Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

Indonesia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Thailand Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Singapore Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Malaysia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Philippines Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Vietnam Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Myanmar Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Iran Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

United Arab Emirates Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Israel Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Iraq Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Qatar Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Kuwait Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Oman Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

Nigeria Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Algeria Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Morocco Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

Australia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

New Zealand Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

South America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Columbia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Chile Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Venezuelal Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Peru Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Puerto Rico Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Ecuador Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2021

Kazakhstan Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate (2016-2021)

Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2021

Sales Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2021

Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume Market Share by Application in 2021

Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Specification

Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists

Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis

Channels of Distribution

Distributors Profiles

Porter's Five Forces Analysis

Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity Growth Rate Forecast (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Global Glucagon Like Peptide-1 (GLP-1) Agonists Price and Trend Forecast (2016-2027)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Forecast (2022-2027)

Rest of the World Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate Forecast (2022-2027)

North America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

East Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

South Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Oceania Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

South America Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Rest of the world Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast 2022-2027

Bottom-up and Top-down Approaches for This Report